Current News Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase 3 poetyk trials Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase 3 poetyk trials 2024-01-16 04:00:00 Differences between the true reproduction number and the apparent reproduction number of an epidemic time series Differences between the true reproduction number and the apparent reproduction number of an epidemic time series 2024-01-16 04:00:00 Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19) Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19) 2024-01-16 04:00:00 Centring health workers and communities is key to building vaccine confidence online Centring health workers and communities is key to building vaccine confidence online 2024-01-16 04:00:00 Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome Risk Factors for Antiphospholipid Antibodies and Antiphospholipid Syndrome 2024-01-16 04:00:00 Pagination First page « First Previous page ‹ Previous … Page 424 Page 425 Page 426 Page 427 Current page 428 Page 429 Page 430 Page 431 Page 432 … Next page Next › Last page Last » PICO Search Aid Problem/Population Intervention Comparison Outcome
